Target intelligence / Profile preview

Immune and stromal cells via paracrine and cell-cell interactions

Molecular classification
Biological process, Cell-cell interaction network, Not a single molecular target
01

Overview

The phrase Immune and stromal cells via paracrine and cell-cell interactions refers to the complex communication network within a tissue microenvironment, most notably the tumor microenvironment (TME). This interaction involves the exchange of biochemical signals through paracrine factors, such as cytokines and growth factors, as well as direct physical contact between cell surface molecules (Nature Reviews Cancer, 2021). Stromal cells, including cancer-associated fibroblasts and endothelial cells, actively modulate the behavior of immune cells to create either a pro-inflammatory or an immunosuppressive niche (NIH, 2023). In the context of cancer, these interactions often promote tumor progression, metastasis, and resistance to therapy by excluding cytotoxic T cells or inducing an exhausted phenotype. Because this term encompasses a broad set of biological processes and numerous distinct molecular pathways, it does not represent a single therapeutic target but rather a systemic context for drug action. Therapeutic strategies often aim to disrupt specific nodes within this network, such as the TGF-beta or CXCL12/CXCR4 axes, to restore anti-tumor immunity or inhibit fibrosis (PubMed, 2022).

Other names
Tumor microenvironment crosstalkImmune-stromal niche signalingParacrine signaling in the tissue nicheCell-cell communication in the microenvironment
02

Mechanism of action

Disruption of paracrine signaling loops or physical cell-cell adhesion/activation within the microenvironment to reprogram the tissue niche.

03

Biological functions

Paracrine signalingCell-cell communicationImmune modulationExtracellular matrix remodelingAngiogenesisTissue homeostasis
04

Disease associations

CancerFibrosisChronic inflammationAutoimmune disease
05

Safety considerations

Systemic toxicity due to pleiotropic effectsOff-target immune activation (autoimmunity)Impaired wound healingCytokine release syndrome
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Multiplex immunofluorescence for cell proximityCytokine and chemokine arraysSingle-cell RNA sequencing signaturesCancer-associated fibroblast (CAF) density

Beyond the preview

Go deeper on Immune and stromal cells via paracrine and cell-cell interactions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune and stromal cells via paracrine and cell-cell interactions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call